In this video, Motley Fool health-care analyst David Williamson discusses what investors should look for in Biogen Idec's upcoming earnings report, and what the Big Biotech has in store for 2013.
Free Article
Foolish Preview: Biogen Earnings
By Dave Williamson
–
Jan 26, 2013 at 8:31AM
NASDAQ: BIIB
Biogen
Market Cap
$29B
Today's Change
(-1.13%) -$2.29
Current Price
$199.70
Price as of April 25, 2024, 11:51 a.m. ET
What investors should look for in Biogen's fourth quarter.
David Williamson has no position in any stocks mentioned. Follow him on Twitter: @MotleyDavid.
The Motley Fool recommends Quest Diagnostics. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Related Articles
Why Biogen Stock Leaped Nearly 5% Higher Today
Biogen (BIIB) Q1 2024 Earnings Call Transcript
1 Wall Street Analyst Thinks Biogen Stock Is Going to $311. Is It a Buy Around $223?
Biogen (BIIB) Q4 2023 Earnings Call Transcript
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
619%
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.